Reliable choice in therapy of type 2 diabetes mellitus: focus on alogliptin
Keyword(s):
This paper discusses the possibilities and benefits of early combination therapy and the application features of a fixed-dose combination of metformin and alogliptin (Vipdomet®) in the treatment of type 2 diabetes mellitus (DM 2).
2013 ◽
Vol 14
(4)
◽
pp. 361-370
◽
2019 ◽
Keyword(s):